CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.
Palacios Araya D, Palmer KL, Duerkop BA. CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. PLoS Pathog. 2021 07; 17(7):e1009672.